Latest Commercialization News

South Africa’s Minister of Mineral Resources has upheld Renergen’s helium extraction rights at the Virginia Gas Project, rejecting an appeal from Springbok Solar and securing the company’s production future.

Proteomics International has validated its PromarkerEndo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis, with commercial launch planned in Australia for Q3 2025. The test promises to reduce the average seven-year diagnostic delay by providing a simple risk score applicable across all disease stages.

Osteopore Limited has drawn down an additional A$500,000 from the first tranche of its redeemable convertible notes, bringing total subscriptions close to the A$5 million tranche limit. The funds will support ongoing operations and future growth initiatives.

360 Capital Mortgage REIT (TCF) has announced a Unit Purchase Plan offering eligible unitholders the chance to buy new units at net asset value, aiming to raise up to $11.1 million to fund commercial real estate loans with a forecast 10.4% yield.

Empire Energy Group Limited has opened a Share Purchase Plan (SPP) offering eligible shareholders the chance to invest up to $30,000 at $0.16 per share, matching a recent institutional placement price. The SPP includes free attaching options, subject to shareholder approval, to support key development projects in the Beetaloo Basin.

Solvar Limited has taken a strategic step by acquiring a 19.9% stake in Earlypay Limited, aiming to broaden its footprint in the SME finance sector. This move aligns with Solvar’s focus on underserved commercial markets.

MTM Critical Metals has confirmed the scalability of its Flash Joule Heating reactor, paving the way for commercial operations at its Texas facility later this year. The modular design promises potential throughput beyond initial targets.

Premier1 Lithium has reported promising high-grade gold mineralisation from maiden drilling at its Yalgoo and Abbotts North projects in Western Australia, highlighting significant exploration upside across extensive greenstone belts.

EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.

EBR Systems has raised A$55.9 million through a fully underwritten placement to fund the commercial rollout of its FDA-approved wireless cardiac pacing system, with plans for a limited market release in H2 2025 and expanded distribution in 2026.

Provaris Energy has partnered with Yinson to develop large-scale liquid CO2 storage tanks and shipping solutions, aiming to meet surging demand in the expanding carbon capture and storage market.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.